A meta-analysis suggests that a combination of a decrease in α-synuclein and total tau and an increase in Nfl in cerebrospinal fluid (CSF) distinguishes MSA patients from healthy controls [95]. The gene discussed is SNCA; the disease is multiple system atrophy.